Kazuyoshi Saito Selected Research

tocilizumab (atlizumab)

1/2024	Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders.
1/2021	Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.
1/2018	Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study.
7/2016	Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.
3/2015	Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.
5/2014	Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
5/2014	Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
1/2014	Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
1/2014	Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
11/2012	Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuyoshi Saito Research Topics

Disease

70	Rheumatoid Arthritis 01/2024 - 05/2003
20	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 10/2003
16	Neoplasms (Cancer) 01/2022 - 01/2002
8	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2023 - 12/2007
8	Inflammation (Inflammations) 01/2019 - 12/2006
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2002
7	Carcinoma (Carcinomatosis) 01/2006 - 07/2002
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2002
6	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020 - 03/2009
6	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2007
6	Infections 08/2012 - 02/2004
5	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2023 - 06/2002
5	Fever (Fevers) 10/2022 - 06/2009
5	Vasculitis (Vasculitides) 01/2022 - 12/2003
5	Neoplasm Metastasis (Metastasis) 10/2005 - 04/2002
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2024 - 01/2021
4	Arthritis (Polyarthritis) 01/2021 - 02/2004
3	Spontaneous Remission 01/2024 - 01/2022
3	Pulmonary Arterial Hypertension 07/2023 - 12/2020
3	Mixed Connective Tissue Disease (MCTD) 07/2023 - 01/2005
3	Pneumonia (Pneumonitis) 01/2022 - 03/2009
3	Immunoglobulin G4-Related Disease 01/2022 - 12/2012
3	Heart Failure 12/2014 - 11/2009
3	Lung Diseases (Lung Disease) 02/2014 - 11/2012
3	Opportunistic Infections (Opportunistic Infection) 11/2012 - 01/2005
3	Synovitis 06/2012 - 05/2003
2	Necrosis 01/2023 - 01/2021
2	Disease Progression 01/2022 - 04/2011
2	Exanthema (Rash) 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 01/2022 - 10/2009
2	Microscopic Polyangiitis 01/2022 - 01/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 11/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2020
2	Adenoma (Adenomas) 01/2020 - 02/2004
2	Behcet Syndrome (Behcet's Syndrome) 01/2019 - 08/2009
2	Lupus Nephritis 01/2017 - 01/2017
2	Osteoporosis 11/2016 - 01/2012
2	Pathologic Processes 11/2016 - 11/2013
2	Bone Resorption 11/2016 - 08/2004
2	Bone Fractures (Bone Fracture) 11/2016 - 11/2008
2	Dermatomyositis (Dermatopolymyositis) 01/2012 - 01/2008
2	Atrophy 05/2011 - 10/2009
2	Body Weight (Weight, Body) 04/2011 - 08/2002
2	Sjogren's Syndrome (Sjogren Syndrome) 10/2009 - 12/2003

Drug/Important Bio-Agent (IBA)

16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2008
14	tocilizumab (atlizumab)FDA Link 01/2024 - 01/2009
14	Infliximab (Remicade)FDA Link 12/2017 - 01/2007
11	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2007
10	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2002
10	Etanercept (Enbrel)FDA Link 09/2016 - 01/2009
9	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 07/2011
9	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2018 - 12/2004
8	GlucocorticoidsIBA 01/2022 - 01/2004
8	Abatacept (Orencia)FDA Link 01/2018 - 01/2014
7	CytokinesIBA 03/2024 - 08/2002
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2009
7	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 02/2004
6	Antirheumatic Agents (DMARD)IBA 01/2024 - 02/2004
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2003
6	Monoclonal AntibodiesIBA 01/2020 - 01/2008
5	Adalimumab (Humira)FDA Link 09/2020 - 06/2012
4	Intravenous Immunoglobulins (IVIG)FDA Link 11/2023 - 11/2021
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2007
4	AntibodiesIBA 11/2023 - 01/2019
4	SteroidsIBA 07/2023 - 10/2003
4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2007
4	Fluorouracil (Carac)FDA LinkGeneric 03/2003 - 11/2002
3	Immunoglobulin G (IgG)IBA 11/2023 - 08/2018
3	EnzymesIBA 01/2023 - 01/2003
3	InterferonsIBA 01/2020 - 06/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 03/2011
3	AutoantibodiesIBA 01/2019 - 01/2009
3	alfacalcidolIBA 11/2016 - 01/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2009
3	Etidronic Acid (HEDP)FDA LinkGeneric 01/2012 - 01/2004
2	Certolizumab Pegol FDA Link 01/2021 - 01/2021
2	Thymidine Monophosphate (TMP)IBA 01/2020 - 01/2017
2	Trimethoprim (Proloprim)FDA LinkGeneric 01/2020 - 01/2017
2	Sulfamethoxazole FDA LinkGeneric 01/2020 - 01/2017
2	CT-P13IBA 03/2017 - 01/2015
2	3-benzoyl dopamine (MBDA)IBA 11/2016 - 05/2015
2	Diphosphonates (Bisphosphonates)IBA 11/2016 - 11/2008
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2016 - 11/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 06/2009
2	tofacitinibIBA 05/2014 - 06/2012
2	Syk KinaseIBA 01/2012 - 06/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2011 - 03/2010
2	Dopamine (Intropin)FDA LinkGeneric 03/2011 - 02/2009
2	Adenosine Triphosphate (ATP)IBA 04/2010 - 12/2002
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2010 - 04/2007
2	mizoribineIBA 10/2009 - 12/2003

Therapy/Procedure

39	Therapeutics 01/2024 - 11/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
4	Laparotomy 07/2006 - 01/2003
4	Pancreaticoduodenectomy 01/2006 - 08/2002
4	Intravenous Infusions 03/2003 - 06/2002
3	Remission Induction 01/2023 - 12/2017
3	Lymph Node Excision (Lymph Node Dissection) 01/2006 - 07/2002
2	Traction 05/2016 - 02/2003
2	Biological Therapy 02/2014 - 11/2012